Trademarkia Logo

Canada

C$
ALYFTREK
APPROVED

on 6 May 2025

Last Applicant/ Owned by

Vertex Pharmaceuticals Incorporated

50 Northern AvenueBoston MA 02210

US

Serial Number

2310673 filed on 17th Jan 2024

ALYFTREK

Trademark usage description

pharmaceutical preparations for the treatment of cystic fibrosis.

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cystic fibrosis.


Classification kind code

12

Mark Details


Serial Number

2310673

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 26
on 6th May 2025
Approved
Submitted for opposition 27
on 6th May 2025
Approval Notice Sent
Submitted for opposition 22
on 28th Apr 2025
Search Recorded
Submitted for opposition 256
on 16th Dec 2024
Notification of Possible Opposition Sent
Submitted for opposition 257
on 15th Feb 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 14th Feb 2024
Created
Submitted for opposition 31
on 14th Feb 2024
Formalized
Submitted for opposition 30
on 17th Jan 2024
Filed
Submitted for opposition 228
on 17th Jan 2024
International Registration